In-silico based vaccine development: targeting nucleocapsid protein of SARS-CoV-2.
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
| Autor principal: | Iva, Yesmine Akter |
|---|---|
| Outros Autores: | Siam, Mohammad Kawsar Sharif |
| Formato: | Thesis |
| Idioma: | English |
| Publicado em: |
Brac University
2022
|
| Assuntos: | |
| Acesso em linha: | http://hdl.handle.net/10361/17040 |
Registos relacionados
-
An in silico Method to developing an epitope-based peptide vaccination against SARS-CoV-2's Envelope Protein (E)
Por: Intesar, Mohammad Nafees
Publicado em: (2023) -
Overview of the risk factors, prevention and management of SARS-COV-2
Por: Mustafa, Nashrah
Publicado em: (2021) -
Omicron, delta, and beta, deadliest among SARS-CoV-2 variants: an in silico analysis
Por: Bosu, Sagar
Publicado em: (2023) -
Detection of genetic diversity of SARS-CoV-2 in wastewater to monitor COVID-19 transmission
Por: Sarwar, Subyeta Binte
Publicado em: (2024) -
An in Silico approach to multi-epitope subunit vaccine development against SARS COV-2 using Membrane Glycoprotein
Por: Rafsan, Rian
Publicado em: (2021)